The Pharmacy Times® Infectious Disease Resource Center is a comprehensive resource for clinical news and expert insights on a group of disorders caused by organisms, such as bacteria, viruses, fungi, or parasites.
January 31st 2023
The FDA approved a new azole antifungal for recurrent vulvovaginal candidiasis.
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy Settings
Although pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Read More
Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, Control
November 7th 2022A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.
Read More
Letermovir Shows Efficacy Preventing Cytomegalovirus Disease in Adults After Kidney Transplantation
October 26th 2022The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.
Read More
Monkeypox Treatment and Prevention: Stopping the Latest Outbreak
There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Read More